Stay updated on Nivolumab Combo in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head and Neck Cancer Clinical Trial page
- Check2 days agoChange DetectedHead and neck squamous cell carcinoma was added as a topic, and MedlinePlus Genetics is listed as a related topic. The revision note shows Revision: v3.3.2, replacing v3.3.1.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1, a technical version change with no impact on the study information or how the page is used. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange Detected- Added a new study site: Tainan, Taiwan, 704.SummaryDifference0.4%

- Check23 days agoChange DetectedAdded related topics: Head and neck squamous cell carcinoma and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check30 days agoChange DetectedThe new screenshots show minor user interface/layout adjustments without changing the core study content; the title, NCT number, interventions, primary outcomes, and eligibility criteria remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check45 days agoChange DetectedAdded a new MedlinePlus Genetics topic on head and neck squamous cell carcinoma to the page.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.